Mixed
Combining GLP-1 pharmacotherapy with promyogenic agents (e.g., bimagrumab, enobosarm), structured resistance exercise, and targeted nutrition (protein/HMB) mitigates lean mass loss and improves functional outcomes compared to GLP-1 monotherapy.
Do not rely on GLP-1 medication alone. To protect your muscles and strength, you must combine your medication with resistance exercise, ensure you are eating enough protein, and ask your doctor about emerging combination therapies like promyogenic agents that specifically target muscle preservation.
combining enobosarm with semaglutide reduced lean mass loss by 71% and yielded a 27% greater reduction in fat mass compared to semaglutide alone. Notably, this combination also led to superior preservation of stair-climbing power and lower-extremity strength
Why this rating
Cites specific trials (QUALITY, bimagrumab RCT) but notes these are emerging strategies requiring further investigation.
Source
Moving beyond the scale: musculoskeletal risks, evidence gaps and emerging combination strategies to optimize the quality of weight loss pharmacotherapy in older adults
Kieran F. Reid et al. · Frontiers in Aging · 2025
DOI 10.3389/fragi.2025.1640030
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →